Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byMallinckrodt
Price$1.3B
Date2/2014

General Information

Websitecadencepharm.com
CategoryBioTech
Phone858-436-1400
Emailinfo@cadencepharm...
Employees
Founded2004
DescriptionBiopharmaceutical company

Offices

San Diego, USA
12481 High Bluff Drive
Suite 200
San Diego, CA, 92130
USA

People

President & CEO
Board Member
Board Member
Board of Directors
Board of Directors
Senior Vice President, Chief Financial Officer, Treasurer and Assistant Secretary
Investor

Tags

Cadence Pharmaceuticals

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

Recent Milestones

Videos

Screenshots

Cadence Pharmaceuticals screenshot
Above: Cadence Pharmaceuticals
Uploaded: 3/13/13

Sources

  1. Mallinckrodt expands specialty unit with $1.3-billion deal to buy Cadence Pharmaceuticals (firstwordpharma.com) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy